TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 86 filers reported holding TRICIDA INC in Q4 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $70,574 | +959.4% | 461,569 | -27.4% | 0.00% | -100.0% |
Q3 2022 | $6,662 | +636.9% | 635,744 | +580.6% | 0.00% | – |
Q2 2022 | $904 | -99.9% | 93,404 | -39.1% | 0.00% | – |
Q1 2022 | $1,261,000 | +106.4% | 153,415 | +139.9% | 0.00% | – |
Q4 2021 | $611,000 | +75.1% | 63,948 | -14.9% | 0.00% | – |
Q3 2021 | $349,000 | -74.5% | 75,125 | -76.3% | 0.00% | – |
Q2 2021 | $1,369,000 | +263.1% | 316,844 | +343.9% | 0.00% | – |
Q1 2021 | $377,000 | -50.7% | 71,377 | -34.2% | 0.00% | – |
Q4 2020 | $765,000 | -46.2% | 108,549 | -30.8% | 0.00% | – |
Q3 2020 | $1,422,000 | -7.4% | 156,919 | +180.6% | 0.00% | – |
Q2 2020 | $1,536,000 | +2.3% | 55,922 | -18.1% | 0.00% | -100.0% |
Q1 2020 | $1,502,000 | -64.7% | 68,262 | -39.4% | 0.00% | 0.0% |
Q4 2019 | $4,252,000 | -4.1% | 112,678 | -21.5% | 0.00% | 0.0% |
Q3 2019 | $4,432,000 | +118.4% | 143,575 | +179.3% | 0.00% | 0.0% |
Q2 2019 | $2,029,000 | +109.6% | 51,410 | +105.1% | 0.00% | – |
Q1 2019 | $968,000 | +79.3% | 25,066 | +9.5% | 0.00% | – |
Q4 2018 | $540,000 | – | 22,886 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 7,132,079 | $69,039,000 | 13.60% |
STONEHILL CAPITAL MANAGEMENT LLC | 1,436,736 | $13,908,000 | 9.25% |
COMMODORE CAPITAL LP | 2,028,453 | $19,635,000 | 4.15% |
Tri Locum Partners LP | 731,142 | $7,077,000 | 2.90% |
GREAT POINT PARTNERS LLC | 1,164,763 | $11,275,000 | 2.70% |
Frazier Life Sciences Management, L.P. | 2,082,093 | $20,155,000 | 1.90% |
Orbimed Advisors | 10,280,947 | $99,520,000 | 1.80% |
Deep Track Capital, LP | 2,732,117 | $26,447,000 | 1.74% |
Lion Point Capital, LP | 1,826,729 | $12,034,000 | 1.37% |
Bleichroeder LP | 450,000 | $4,356,000 | 0.90% |